Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Nepafenac (0.3% w/v) Eye Drops
Therapeutic Category
Anti-Inflammatories, Ophthalmology
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
10ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Nepastep Plus Eye Drops are formulated with Nepafenac (0.3% w/v), a clinically proven ophthalmic NSAID. It helps in reducing ocular pain, inflammation, redness, and swelling, especially after cataract surgery and other ophthalmic procedures.
Nepafenac works by penetrating ocular tissues and inhibiting prostaglandin synthesis, ensuring targeted and sustained anti-inflammatory action within the eye. This results in faster recovery and improved patient comfort during the post-operative period.
The once-daily 0.3% strength improves patient compliance and is widely preferred by ophthalmologists for post-surgical eye care protocols.
From a business perspective, Nepastep Plus Eye Drops strengthen the post-operative ophthalmic segment, delivering high prescription frequency, repeat demand, and long-term profitability for PCD pharma franchise partners.
Common side effects may include mild burning or stinging sensation, blurred vision, eye irritation, redness, or dryness after instillation. Rarely, delayed wound healing, increased intraocular pressure, or hypersensitivity reactions may occur.
Nepastep Plus Eye Drops are indicated for the management of postoperative ocular pain and inflammation, especially after cataract surgery. They are also used in other inflammatory eye conditions as advised by an ophthalmologist.
Use Nepastep Plus Eye Drops strictly under the supervision of an ophthalmologist. Avoid touching the dropper tip to the eye or any surface to prevent contamination. Do not use for prolonged periods without medical advice. Discontinue use and consult a doctor immediately if severe irritation, vision changes, or allergic reactions occur.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.
Composition : Carboxymethylcellulose (1% w/v) + Oxychloro Complex (0.0075% w/v)
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Nepafenac 0.3% w/v Eye Drops have strong demand in the ophthalmology, post-operative eye care, and anti-inflammatory segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced eye care portfolios.
Medical distributors and agencies can benefit from consistent demand for ocular inflammation and post-operative eye care management under ophthalmologist supervision. Nepafenac 0.3% w/v is a non-steroidal anti-inflammatory drug (NSAID) formulated for ophthalmic use Commonly prescribed for pain and inflammation associated with cataract surgery and other ophthalmic procedures Helps reduce post-operative ocular discomfort, inflammation, and swelling Acts by inhibiting the production of prostaglandins that contribute to inflammation and pain Convenient once-daily dosing may enhance patient compliance as directed by healthcare professionals Widely prescribed by ophthalmologists and eye surgeons This strengthens a comprehensive ophthalmology and post-operative eye care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Nepafenac 0.3% w/v Eye Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady demand in eye hospitals, ophthalmology clinics, and surgical eye care centers, along with repeat prescriptions, reliable supply chain support, and attractive margins in the ophthalmic specialty segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.